Prediction Case File
YouTubeTracking Live

Analyzing 7 Big Tech Stocks: Best to WORST!

2 extracted signals · 0 resolved · 2 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
31 Oct 2026, 14:41 UTC
Recorded by Tahlil Plus
31 Oct 2026, 16:19 UTC
Video preview for Analyzing 7 Big Tech Stocks: Best to WORST!
Source overview

AI-generated source summary

The analysis covers several tech stocks, with a focus on their current performance and future outlook. GOOGL is identified as a strong buy despite recent performance, with a target price of $308.55 and a fail bound at $260.00, suggesting a bullish outlook on its long-term growth potential driven by AI and cloud services. AMZN is placed in the 'wait' category due to mixed signals, with a target of $140.00 and a fail bound at $115.00, reflecting a cautious stance on its advertising business. AVGO is also flagged as a buy with a target of $400.00 and a fail bound at $280.00, underpinned by its strategic acquisitions and AI chip deals, despite current market pricing. Microsoft (MSFT) and Apple (AAPL) are noted for their strong operational metrics and growth potential, with MSFT being a buy and AAPL placed in 'avoid' due to its high valuation and recent price action. The analysis highlights the importance of valuation and future growth drivers, particularly in AI and cloud computing, for investment decisions.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
2
Extracted from this source
Open
2
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    2 eligible signals linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Live evaluation in progress

    2 signals remain active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
362
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail